Vascular Diseases  >>  hydrocortisone  >>  Phase 2
Welcome,         Profile    Billing    Logout  

5 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
hydrocortisone / Generic mfg.
NCT00002552: Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Multiple Myeloma

Completed
2
40
US
filgrastim, sargramostim, carmustine, cyclophosphamide, cytarabine, etoposide, leucovorin calcium, methotrexate, perfosfamide, therapeutic hydrocortisone, allogeneic bone marrow transplantation, autologous bone marrow transplantation, in vitro-treated bone marrow transplantation, peripheral blood stem cell transplantation, syngeneic bone marrow transplantation, radiation therapy
Barbara Ann Karmanos Cancer Institute, National Cancer Institute (NCI)
Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm
09/01
10/03
NCT00185614: Non-myeloablative Allogeneic Transplantation for the Treatment of Multiple Myeloma

Completed
2
63
US
Autologous hematopoietic cell transplant (Auto-HCT), Allogeneic hematopoietic cell transplant (Allo-HCT), Cyclophosphamide, Cytoxan, Neosar, Filgrastim, Neupogen, Granulocyte-colony stimulating factor (G-CSF), Melphalan, Melphalan hydrochloride, Melphalan HCl, Total body irradiation (TBI), Cyclosporine (CSP), Cyclosporine A, Mycophenolate Mofetil (MMF), CellCept
Wen-Kai Weng
Blood Cancer, Multiple Myeloma
04/09
04/10
MENHIR, NCT01726465: Methylprednisolone N Acetylcysteine in Hepatic Resections

Terminated
2
50
Europe
Methylprednisolone, methylprednisolone sodium succinate, N-acetylcysteine, N-acetyl cysteine
Istituto Clinico Humanitas
Ischemic Reperfusion Injury, Insufficiency; Hepatic, Postoperative, Liver Tumour
10/13
11/13
NCT00899847: Phase 2 Study of Autologous Followed by Nonmyeloablative Allogeneic Transplantation Using TLI & ATG

Completed
2
9
US
Autologous peripheral blood stem cells (auto-PBSC) transplantation, auto-PBPC, Autologous peripheral blood progenitor cells (auto-PBPC) transplantation, Allogeneic peripheral blood stem cells (allo-PBSC) transplantation, allo-PBSC, Allogeneic peripheral blood progenitor cells (allo-PBPC) transplantation, Filgrastim, Neupogen, Granulocyte colony-stimulating factor (G-CSF), r-metHuG-CSF, Cyclophosphamide, Ciclofosfamida, Ciclofosfamide, Claphene, CP monohydrate (CPM), CSP, Melphalan, L-Sarcolysin, L-phenylalanine mustard (L-PAM), L-Sarcolysin phenylalanine mustard, L-sarcolysine, Cyclosporine, Cyclosporin, Cyclosporin A, Ciclosporin, Total lymphoid irradiation, TLI, Rabbit anti-thymocyte globulin, Thymoglobulin, ATG, Mycophenolate Mofetil 250mg, CellCept, MMF, Solumedrol, Solumedin, Soludecadron, Diphenhydramine, Benadryl, Acetaminophen, Tylenol, Hydrocortisone
Stanford University
Transplantation, Homologous, Transplantation, Autologous, Multiple Myeloma, Blood and Marrow Transplant (BMT)
04/14
12/14
NCT00626626: Clofarabine and Non-Myeloablative Allogeneic Hematopoietic Transplantation

Terminated
1/2
8
US
Clofar, Cyclophos, Alemtuzumab, CLOLAR, Clofar, Cyclophos,Alemtuzumab(Ph II), Clolar, Campath
Milton S. Hershey Medical Center
Leukemia, Myelodysplastic Syndrome, Chronic Myelogenous Leukemia, Lymphoma, Hodgkin's Lymphoma, Multiple Myeloma
01/10
01/10

Download Options